Data di Pubblicazione:
2003
Citazione:
Pharmaceutical expenditure: Aspects of cost containment in Italy / L. Scalone, S. De Portu, P. Minghetti, L.G. Mantovani. - In: JOURNAL OF PHARMACEUTICAL FINANCE ECONOMICS & POLICY. - ISSN 1538-5396. - 12:4(2003), pp. 337-350. [10.1300/J371v12n04_06]
Abstract:
Italy has had a national health service since 1978, to provide access to care to all citizens. The service uses 3-year plans to aim to meet demands and needs. The pharmaceutical sector is well developed with regard to R & D and production. Drug prices are fixed based on comparison prices in other European countries. Position within 3 classes of drugs determines the level of patient co-payment. Genetics have been recognized and included since 1996. Numerous recent events are likely to change the pharmaceutical sector, since recent regulations have not succeeded in reducing prices or utilization.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Drug reimbursement; Generic drugs; National health service
Elenco autori:
L. Scalone, S. De Portu, P. Minghetti, L.G. Mantovani
Link alla scheda completa: